News & Insights

Vir Biotechnology announces its underwritten public offering of 20,294,117 shares of common stock at $8.50 per share, including the exercise in full of the underwriters’ option to purchase additional shares.

Multi-specialty telehealth platform, Hims & Hers Health, announces its acquisition of MedisourceRx, a 503B outsourcing facility in California 

Biopharmaceutical company, Tarsus Pharmaceuticals, announces its $115.0 million public offering to continue advancing its pipeline to address several diseases.